GlassScriptPhysician profile
Tracy Katherine Wick
NPI 1174617203
$3,113.61
in general payments reported to CMS, 2019-2025
14 companies · $447 in 2025
The $447 reported for 2025 was more than what 90% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $891 · 2020: $36.66 · 2021: $91.66 · 2022: $214 · 2023: $977 · 2024: $457 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,880.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,880.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $886.93 | 2019-2025 | Skyrizi, Rinvoq |
| Eli Lilly and Company | $707.22 | 2019 | |
| Lilly USA, LLC | $270.43 | 2022-2024 | Olumiant, Taltz, Zepbound |
| Organogenesis INC. | $211.82 | 2024-2025 | Affinity, Novachor, Puraply Wound Matrix |
| Amgen INC. | $180.25 | 2024-2025 | Otezla, Otezla, Blincyto |
| Pfizer INC. | $142.58 | 2023-2024 | |
| Ucb, INC. | $138.32 | 2023-2024 | Cimzia, Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $124.99 | 2023 | Sotyktu |
| Genzyme Corporation | $102.92 | 2023 | |
| Biofrontera INC. | $93.85 | 2024-2025 | Ameluz, Rhodoled Xl, Xepi |
| Regeneron Healthcare Solutions, INC. | $84.13 | 2023 | Dupixent |
| Janssen Biotech, INC. | $81.78 | 2024 | Tremfya |
| Sun Pharmaceutical Industries INC. | $72.34 | 2023-2024 | Blu-U |
| Leo Pharma INC. | $16.05 | 2024 | Adbry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Wick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.